Original Article

You have full text access to this OnlineOpen article

Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma

A multivariate analysis of clinical risk factors

  1. Andreas Machens M.D.1,†,*,
  2. Hans-Jürgen Holzhausen M.D.2,
  3. Christine Lautenschläger Ph.D.3,
  4. Phuong Nguyen Thanh M.D.1,
  5. Henning Dralle M.D.1

Article first published online: 11 JUL 2003

DOI: 10.1002/cncr.11581

Issue

Cancer

Cancer

Volume 98, Issue 4, pages 712–719, 15 August 2003

Additional Information

How to Cite

Machens, A., Holzhausen, H.-J., Lautenschläger, C., Thanh, P. N. and Dralle, H. (2003), Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma. Cancer, 98: 712–719. doi: 10.1002/cncr.11581

Author Information

  1. 1

    Department of General, Visceral and Vascular Surgery, Martin-Luther-Universität Halle-Wittenberg, Halle/Saale, Germany

  2. 2

    Department of Pathology, Martin-Luther-Universität Halle-Wittenberg, Halle/Saale, Germany

  3. 3

    Department of Medical Epidemiology, Biometrics and Informatics, Martin-Luther-Universität Halle-Wittenberg, Halle/Saale, Germany

  1. †

    Fax: (011) 49 345 557 2551

*Department of General, Visceral and Vascular Surgery, Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Straße 40, D-06097 Halle/Saale, Germany

Publication History

  1. Issue published online: 1 AUG 2003
  2. Article first published online: 11 JUL 2003
  3. Manuscript Revised: 16 MAY 2003
  4. Manuscript Accepted: 16 MAY 2003
  5. Manuscript Received: 18 FEB 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (87K)

REFERENCES

  • 1
    Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature. 1998; 396: 643–649.
  • 2
    Wreesmann VB, Ghossein RA, Patel SG, et al. Genome-wide appraisal of thyroid cancer progression. Am J Pathol. 2002; 161: 1549–1556.
  • 3
    Russo A, Zanna I, Tubiolo C, et al. Hereditary common cancers: molecular and clinical genetics. Anticancer Res. 2000; 20: 4841–4851.
  • 4
    Wada N, Duh QY, Miura D, Brunaud L, Wong MG, Clark OH. Chromosomal aberrations by comparative genomic hybridization in Hürthle cell thyroid carcinomas are associated with tumor recurrence. J Clin Endocrinol Metab. 2002; 87: 4595–4601.
  • 5
    Machens A, Hinze R, Thomusch O, Dralle H. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg. 2002; 26: 22–28.
  • 6
    Hinze R, Holzhausen HJ, Gimm O, Dralle H, Rath FW. Primary hereditary medullary thyroid carcinoma—C-cell morphology and correlation with preoperative calcitonin levels. Virchows Arch. 1998; 433: 203–208.
  • 7
    World Health Organization. International histological classification of tumours, 2nd edition. Berlin: Springer-Verlag, 1988.
  • 8
    FlemingID, CooperJS, HensonDE, et al., editors. American Joint Committee on Cancer staging manual, 5th edition. Philadelphia: Lippincott-Raven, 1998.
  • 9
    SobinLH, WittekindC, editors. TNM classification of malignant tumors, 5th edition. New York: John Wiley & Sons, 1997.
  • 10
    Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998; 280: 1690–1691.
  • 11
    Dralle H, Damm I, Scheumann GFW, et al. Compartment oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today. 1994; 24: 112–121.
  • 12
    HennekensCH, BuringJE, MayrentSL, editors. Epidemiology in medicine. Boston: Little, Brown and Company, 1987.
  • 13
    Mirallié E, Sagan C, Hamy A, et al. Predictive factors for node involvement in papillary thyroid carcinoma. Univariate and multivariate analyses. Eur J Cancer. 1999; 35: 420–423.
  • 14
    Hölzer S, Reiners C, Mann K, et al. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group. Cancer. 2000; 89: 192–201.
    Direct Link:
  • 15
    Machens A, Hinze R, Lautenschläger C, Thomusch O, Dunst J, Dralle H. Extended surgery and early postoperative radiotherapy for undifferentiated thyroid carcinoma. Thyroid. 2001; 11: 373–380.
  • 16
    Machens A, Gimm O, Ukkat J, Hinze R, Schneyer U, Dralle H. Improved prediction of calcitonin normalization in medullary thyroid carcinoma by quantitative lymph node analysis. Cancer. 2000; 88: 1909–1915.
    Direct Link:
  • 17
    Grigsby PW, Gal-or A, Michalski JM, Doherty GM. Childhood and adolescent thyroid carcinoma. Cancer. 2002; 95: 724–729.
    Direct Link:
  • 18
    Salvesen H, Njølstad PR, Akslen LA, Albrektsen G, Søreide O, Varhaug JE. Papillary thyroid carcinoma: a multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system. Eur J Surg. 1992; 158: 583–589.
  • 19
    van Heerden JA, Hay ID, Goellner JR, et al. Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery. 1992; 112: 1130–1136; discussion 1136–1138.
  • 20
    Chow SM, Law SCK, Mendenhall WM, et al. Follicular thyroid carcinoma. Prognostic factors and the role of radioiodine. Cancer. 2002; 95: 488–498.
    Direct Link:
  • 21
    Moley JF, DeBenedetti MK. Patterns of nodal metastases in palpable medullary thyroid carcinoma. Recommendations for extent of node dissection. Ann Surg. 1999; 229: 880–887; discussion 887–888.
  • 22
    Beenken S, Roye D, Weiss H, et al. Extent of surgery for intermediate-risk well-differentiated thyroid cancer. Am J Surg. 2000; 179: 51–56.
  • 23
    Kebebew E, Kikuchi S, Duh QY, Clark OH. Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid carcinoma. Arch Surg. 2000; 135: 895–901.
  • 24
    Sivanandan R, Soo KC. Pattern of cervical lymph node metastases from papillary carcinoma of the thyroid. Br J Surg. 2001; 88: 1241–1244.
    Direct Link:
View Full Article (HTML) Get PDF (87K)